This study is testing a device called the AccuraSee™ intraocular pseudophakic capsular lens (IOPCL) to see if it can safely and effectively improve your near and/or intermediate vision after you've already had cataract surgery. You might be able to join if you are 22 years or older and have previously had cataract surgery with specific types of Alcon or Johnson and Johnson monofocal lenses. The researchers will know if the device is successful by measuring improvements in your uncorrected near vision (how well you see up close without glasses) at 12 months. The current status of this study is unclear, and it plans to enroll 10 participants.

Study design

This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 10 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for at least 12 months to measure improvements in their near vision.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.